These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29663918)

  • 1. Theranostic Applications of Antibody-Based Systems in Human Diseases.
    Ding F; Gao Y; He X; Zhang Y
    J Biomed Nanotechnol; 2018 Mar; 14(3):405-429. PubMed ID: 29663918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools.
    Farahavar G; Abolmaali SS; Gholijani N; Nejatollahi F
    Biomater Sci; 2019 Oct; 7(10):4000-4016. PubMed ID: 31355391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a world of theranostic medication: Programming biological sentinel systems for therapeutic intervention.
    Kojima R; Aubel D; Fussenegger M
    Adv Drug Deliv Rev; 2016 Oct; 105(Pt A):66-76. PubMed ID: 27189230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease.
    McEnaney PJ; Parker CG; Zhang AX; Spiegel DA
    ACS Chem Biol; 2012 Jul; 7(7):1139-51. PubMed ID: 22758917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring binding and effector functions of natural human antibodies using synthetic immunomodulators.
    Jakobsche CE; Parker CG; Tao RN; Kolesnikova MD; Douglass EF; Spiegel DA
    ACS Chem Biol; 2013 Nov; 8(11):2404-11. PubMed ID: 24053626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobody: outstanding features for diagnostic and therapeutic applications.
    Salvador JP; Vilaplana L; Marco MP
    Anal Bioanal Chem; 2019 Mar; 411(9):1703-1713. PubMed ID: 30734854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
    Nguyen KT; Zhao Y
    Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors.
    Xiang D; Zheng C; Zhou SF; Qiao S; Tran PH; Pu C; Li Y; Kong L; Kouzani AZ; Lin J; Liu K; Li L; Shigdar S; Duan W
    Theranostics; 2015; 5(10):1083-97. PubMed ID: 26199647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voyage of theranostic liposomes for imaging and therapy.
    Sachin M; Sachin D; Dinesh S
    J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disulfide-based multifunctional conjugates for targeted theranostic drug delivery.
    Lee MH; Sessler JL; Kim JS
    Acc Chem Res; 2015 Nov; 48(11):2935-46. PubMed ID: 26513450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.
    Zanganeh S; Spitler R; Hutter G; Ho JQ; Pauliah M; Mahmoudi M
    Immunotherapy; 2017 Sep; 9(10):819-835. PubMed ID: 28877626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-targeted nanoparticles for cancer treatment.
    Carter T; Mulholland P; Chester K
    Immunotherapy; 2016 Jul; 8(8):941-58. PubMed ID: 27381686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies.
    Howard CB; Fletcher N; Houston ZH; Fuchs AV; Boase NR; Simpson JD; Raftery LJ; Ruder T; Jones ML; de Bakker CJ; Mahler SM; Thurecht KJ
    Adv Healthc Mater; 2016 Aug; 5(16):2055-68. PubMed ID: 27283923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysaccharide-based nanoparticles for theranostic nanomedicine.
    Swierczewska M; Han HS; Kim K; Park JH; Lee S
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):70-84. PubMed ID: 26639578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting and Drug Delivery.
    Xie Z; Su Y; Kim GB; Selvi E; Ma C; Aragon-Sanabria V; Hsieh JT; Dong C; Yang J
    Small; 2017 Mar; 13(10):. PubMed ID: 28026115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in theranostic applications of hybrid gold nanoparticles.
    Gharatape A; Salehi R
    Eur J Med Chem; 2017 Sep; 138():221-233. PubMed ID: 28668475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic of biopharmaceuticals.
    Chaigne B; Watier H
    Pharmacol Ther; 2017 Jul; 175():67-74. PubMed ID: 28223229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
    Vandghanooni S; Eskandani M; Barar J; Omidi Y
    Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
    Shahbazi R; Ozpolat B; Ulubayram K
    Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.